630-580-1088 sales@ambeed.com
Structure Search

List Search MOL Search Structure Search

0
Chemistry
Asymmetric Synthesis >>Chiral Building BlocksChiral Catalysts, Chiral Ligands and Chiral ReagentsChiral Resolution ReagentsCatalysis Chemistry >>Achiral Crown LigandsC-H ActivationCarbon-Donor LigandsChiral Crown LigandsCross-CouplingCross-Coupling Using Transition Metal CatalystsDACH or Trost LigandsDiketone LigandsHydrogenationChemical Biology >>Conjugation ChemistryGlycoscienceLinkers and CrosslinkersNucleic Acid ChemistryPEGylation
Peptide ChemistryPhotolabile Protecting GroupHeterocyclic Building Blocks >>AcridinesAliphatic HeterocyclesAromatic HeterocyclesAzetidinesBenzimidazolesBenzisoxazolesBenzodioxansBenzofuransBenzothiazolesInorganic reagents >>Inorganic reagentOrganic Building Blocks >>Acyl ChloridesAlcoholsAldehydesAliphatic Chain HydrocarbonsAliphatic Cyclic Hydrocarbons
AlkenylsAlkylsAlkynylsAmidesOrganometallic Reagents >>Grignard ReagentsOrganoarsenicOrganobismuthOrganoboronOrganogermaniumOrganolithiumOrganomercuryOrganosiliconOrganotinSpecialty Synthesis >>Enzyme-Mediated SynthesisFluorous SynthesisIonic LiquidsSolid Supported SynthesisStains and Dyes >>
Acid DyesAzoic DyesBasic DyesDirect DyesDisperse DyesDye IntermediatesMordant DyesOil DyesOther Stains and DyesSynthetic Reagents >>Acids and BasesC-C Bond FormationC-X Bond Formation (Halogen)C-X Bond Formation (Non-Halogen)Chelation and Complexation CompoundsCondensation AgentsCouplingDehydrating ReagentsFluorination Reagent
Pharmaceutical Intermediates
Analgesics >>BenzhydrocodoneBicifadineCapsaicinCelecoxibDebio-0827DexamethasoneElagolix SodiumEsketamine HydrochlorideIbuprofen sodiumAnesthetics >>CiprofolEsketamine HydrochlorideFospropofol Fospropofol DisodiumLevobupivacaine RemimazolamRemimazolam BesilateRemimazolam besylateRopivacaineAnti-Addiction Agents >>Kakonein
Lofexidine HydrochlorideVarenicline Anti-inflammatory Agents >>ApremilastAsunaprevirATB-346 RelatedBalsalazide BaricitinibBencycloquidium BromideBudesonideCefiderocol Sulfate TosylateCeftaroline Fosamil AcetateAntibacterials >>AFN-1252 RelatedAlatrofloxacin Bedaquiline FumarateBesifloxacin BrilacidinCaspofungin AcetateCefiderocol Sulfate TosylateCefilavancinCeftaroline Fosamil
Anticonvulsants >>BrivaracetamCannabidiolEscitalopram OxalateEslicarbazepine Acetate RelatedFosphenytoinGabapentin EnacarbilJNJ-10234094LacosamideLevetiracetam RelatedAntidementia Agents >>Azeliragon RelatedDavunetideDonepezil HydrochlorideDonepezil RelatedEnsaculinFlorbetaben Flortaucipir F 18Flutemetamol IdalopirdineAntidepressants >>4-Chlorokynurenine
AgomelatineAgomelatine RelatedAllopregnanolone RelatedAmibegronAmitifadineAripiprazole RelatedBasimglurantBefloxatoneAntiemetics >>AprepitantAprepitant RelatedDolasetron RelatedDolasetron Mesylate HydrateFosaprepitant DimeglumineFosaprepitant RelatedOlanzapinePalonosetron RelatedPalonosetron HydrochlorideAntifungals >>Anidulafungin RelatedCabotegravirMore >>
Inhibitors/Agonists
ADC >>ADC LinkerADC Linker with PayloadADC ToxinAnti-infection >>3CLproAntibacterialAntifungalAntiparasiticAntiprotozoalAntiviralBVDVCMVDengue VirusApoptosis >>Apoptosis InducerBcl-2c-Mycc-RETC/EBPCARDCaspase
DAPKIAPAutophagy >>AutophagyLC3LRRK2LysosomemitoNEETPPTSPHKTFEBULKBiochemical Reagent >>Cationic & Neutral LipidsDendrimersDye ReagentIntermediate and OthersCell Cycle >>APCAurora KinaseBUBCasein Kinase
Cdc25CDKChkCRM1DHFRCytoskeleton >>ActinArp2/3 ComplexCytoplasmic dyneinDynaminFAKFilamin-AGap JunctionIntegrinMicrotubule/TubulinDNA Damage >>AP endonucleaseATAD5ATM/ATRBRCADNA Alkylator/CrosslinkerMore >>
Material Science
Aggregation-Induced Emission >>Other AIE BlocksTetraphenylethylene SeriesElectronic Materials >>Battery MaterialsDye-Sensitized Solar Cell (DSSC) MaterialsElectronic MaterialLiquid Crystal (LC) MaterialsMolecular ConductorsOrganic Light-Emitting Diode (OLED) MaterialsOrganic Solar Cell (OPV) MaterialsOrganic Transistor (OFET) MaterialsPerovskite Solar Cell (PSC) MaterialsMagnetic Materials >>Magnetic Ionic LiquidsMagnetic MaterialMagnetic Metal Complexes Organic Radicals Material Chemical Compounds >>Ligands for Functional Metal ComplexesLiquid Crystal (LC) Building BlocksPhthalocyanine Building BlocksPolymer and Macromolecule Semiconductor Building BlocksSmall Molecule Semiconductor Building BlocksSolubility Enhancing Reagents Supramolecular Host Materials MOF Ligands >>
Carboxylic MOF ligandsMOF ligands of nitrogenous carboxylic acidsNitrogen containing MOF ligandsOther MOF ligandsNanomaterials >>Carbon NanomaterialsCeramic MembranesDendrimersGold NanoparticlesIron Oxide NanoparticlesMaterials by ApplicationMesoporous MaterialsMetals and Metal AlloysNano Minerals: NanoclaysOLED Materials >>DopantHostHTMOLED IntermediatesOther OLED related materialsOLED Materials >>DopantHostHTMOther OLED related metarialsOptical Materials >>Coumarin Dyes
Cyanine and Squarylium DyesDCM DyesDipyrromethene DyesFluorescence MaterialsFluorescent ProbesHeat and Pressure Sensitive DyesNear-Infrared (NIR) DyesOrganic Non-Linear Optical (NLO) MaterialsOrganic monomer of COF >>Aldehyde based COF monomerAlkynyl COF monomerAmino COF monomerBoric acid COF monomerCyano COF monomerMultifunctional COF monomerOther COF monomerTriphene seriesOrganic Pigments >>Organic PigmentOther Materials >>Mateial OtherPolymer Science >>MonomersPolymer AdditivesPolymerization ReagentsPolymersResins
Life Science
ADC-linkers >>ADC-linkerAmino Acids >>Amino AcidAmino Acid DerivativesAnalytical Science >>Stable IsotopesAPIs >>API
DNA/RNA >>Nucleosides and NucleotidesEnzymes >>EnzymeOther Life Science >>CRISPR/Cas9eIFIRE1Neuronal Signaling
Sigma ReceptorPeptides >>PeptideStandard Substrates >>Standard SubstrateSteroids >>Other Steroids
Contact Us
Home Cart 0 Sign in  
X
Chemistry
Heterocyclic Building Blocks
Piperidines
4-Methyl-1,4'-bipiperidine
Chemistry
Heterocyclic Building Blocks
Piperidines
Aliphatic Heterocycles

[ CAS No. 116797-02-5 ]

{[proInfo.proName]} ,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 116797-02-5
Chemical Structure| 116797-02-5
Chemical Structure| 116797-02-5
Structure of 116797-02-5 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Bulk Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

For Research Only 100K+ Compounds Competitive Price 1-2 Day Shipping

Quality Control of [ 116797-02-5 ]

COA NMR CNMR HPLC LC-MS

Related Doc. of [ 116797-02-5 ]

SDS Specification
Alternatived Products of [ 116797-02-5 ]

Product Details of [ 116797-02-5 ]

CAS No. :116797-02-5 MDL No. :MFCD03274731
Formula : C11H22N2 Boiling Point : -
Linear Structure Formula :- InChI Key :MPXFUSKDKWZTPI-UHFFFAOYSA-N
M.W :182.31 Pubchem ID :795715
Synonyms :

Calculated chemistry of [ 116797-02-5 ]

Physicochemical Properties

Num. heavy atoms : 13
Num. arom. heavy atoms : 0
Fraction Csp3 : 1.0
Num. rotatable bonds : 1
Num. H-bond acceptors : 2.0
Num. H-bond donors : 1.0
Molar Refractivity : 64.29
TPSA : 15.27 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.23 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.56
Log Po/w (XLOGP3) : 1.67
Log Po/w (WLOGP) : 0.71
Log Po/w (MLOGP) : 1.81
Log Po/w (SILICOS-IT) : 1.82
Consensus Log Po/w : 1.72

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.96
Solubility : 2.02 mg/ml ; 0.0111 mol/l
Class : Very soluble
Log S (Ali) : -1.6
Solubility : 4.53 mg/ml ; 0.0248 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -1.97
Solubility : 1.95 mg/ml ; 0.0107 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.25

Safety of [ 116797-02-5 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 116797-02-5 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 116797-02-5 ]

[ 116797-02-5 ] Synthesis Path-Downstream   1~68

  • 1
  • N-[(benzyloxy)carbonyl]-4-methyl-[1,4']bipiperidine [ No CAS ]
  • [ 116797-02-5 ]
YieldReaction ConditionsOperation in experiment
64% With hydrogen In ethanol at 20℃; for 2h;
Reference： [1]Semetey, Vincent; Moustakas, Demetri; Whitesides, George M. [Angewandte Chemie - International Edition, 2006, vol. 45, # 4, p. 588 - 591]
  • 2
  • [ 626-58-4 ]
  • [ 116797-02-5 ]
YieldReaction ConditionsOperation in experiment
Multi-step reaction with 2 steps 1: 51 percent / NaBH(OAc)3 / 1,2-dichloro-ethane / 20 °C 2: 64 percent / H2 / Pd/C / ethanol / 2 h / 20 °C
Reference： [1]Semetey, Vincent; Moustakas, Demetri; Whitesides, George M. [Angewandte Chemie - International Edition, 2006, vol. 45, # 4, p. 588 - 591]
  • 3
  • [ 19099-93-5 ]
  • [ 116797-02-5 ]
YieldReaction ConditionsOperation in experiment
Multi-step reaction with 2 steps 1: 51 percent / NaBH(OAc)3 / 1,2-dichloro-ethane / 20 °C 2: 64 percent / H2 / Pd/C / ethanol / 2 h / 20 °C
Reference： [1]Semetey, Vincent; Moustakas, Demetri; Whitesides, George M. [Angewandte Chemie - International Edition, 2006, vol. 45, # 4, p. 588 - 591]
  • 4
  • [ 40064-34-4 ]
  • [ 116797-02-5 ]
YieldReaction ConditionsOperation in experiment
Multi-step reaction with 3 steps 1: 90 percent / Na2CO3 / dioxane; H2O / 2 h / 20 °C 2: 51 percent / NaBH(OAc)3 / 1,2-dichloro-ethane / 20 °C 3: 64 percent / H2 / Pd/C / ethanol / 2 h / 20 °C
Reference： [1]Semetey, Vincent; Moustakas, Demetri; Whitesides, George M. [Angewandte Chemie - International Edition, 2006, vol. 45, # 4, p. 588 - 591]
  • 5
  • [ 116797-02-5 ]
  • [ 911370-07-5 ]
  • [ 911370-51-9 ]
YieldReaction ConditionsOperation in experiment
51% With triethylamine In dichloromethane at -20℃; 51 Example 51; 4-chloro-8-r2,6-difluorophenylV2-('4-methyl-1.4'-bipiperidin-l'-vDρyridor2,3-To the compound 4-chloro~8-(2,6-difluorophenyl)-2-(methylsulfinyl)pyrido[2,3-0C overnight. Filtration followed by concentration, the crude was purified with flash chromatography to afford the title compound (0.904 g, 51%). LC-MS m/z 474 (M+Η)+.
51% With triethylamine In dichloromethane at -20℃; 163.163a Example 163; 3-[8-r2.6-difiuorophenylV2-('4-methyl-l,4'-bipiperidm-r-yl)-7-oxo-7.8- dihydropyrido[2n3-'l-methylethyl)benzamide163a) 4-chloro-8-f2,6-difluorophenylV2-('4-methyl-1.4'-bipiperidin-r-vϖpyrido("2,3-To the compound 4-chloro-8-(2,6-difluorophenyl)-2-(methylsulfinyl)ρyrido[233-0C overnight. Filtration followed by concentration, the crude was purified with flash chromatography to afford the title compound (0.904 g, 51 %). LC-MS m/z 474 (M+Η)+.
51% With triethylamine In dichloromethane at -20℃; 51 To the compound 4-chloro-8-(2,6-difluorophenyl)-2-(methylsulfmyl)pyrido[2,3-J]pyrimidin-7(8H)-one (1.39 g, 3.9 mmol) in dichloromethane (80 mL) were added A- methyl-l,4'-bipiperidine (0.75 g, 5.85 mol) and triethylamine (1.03 mL, 11.7 mmol). The mixture was stirred at about -200C overnight. Filtration followed by concentration, the crude was purified with flash chromatography to afford the title compound (0.904 g, 51%). LC-MS m/z 474 (M+η)+.
51% With triethylamine In dichloromethane at -20℃; 163.163a To the compound 4-chloro-8-(2,6-difluorophenyl)-2-(methylsulfnyl)pyrido[2,3- (i]pyrimidin-7(8H)-one (1.39 g, 3.9 mmol) in dichloromethane (80 mL) were added 4-methyl- 1 ,4'-bipiperidine (0.75 g, 5.85 mol) and triethylamine (1.03 mL, 11.7 mmol). The mixture was stirred at -200C overnight. Filtration followed by concentration, the crude was purified with flash chromatography to afford the title compound (0.904 g, 51%). LC-MS m/z 474 (M+η)+.

Reference： [1]Current Patent Assignee: GLAXOSMITHKLINE PLC - WO2006/104917, 2006, A2 Location in patent: Page/Page column 78
[2]Current Patent Assignee: GLAXOSMITHKLINE PLC - WO2006/104915, 2006, A2 Location in patent: Page/Page column 234
[3]Current Patent Assignee: GLAXOSMITHKLINE PLC - WO2007/147104, 2007, A2 Location in patent: Page/Page column 75
[4]Current Patent Assignee: GLAXOSMITHKLINE PLC - WO2007/147103, 2007, A2 Location in patent: Page/Page column 208
  • 6
  • [ 116797-02-5 ]
  • [ 911693-62-4 ]
  • 3-[8-(2,6-difluorophenyl)-2-(4-methyl-1,4'-bipiperidin-1'-yl)-7-oxo-5,6,7,8-tetrahydropyrimido[4,5-d]pyrimidin-4-yl]-4-methyl-N-(1-methylethyl)benzamide [ No CAS ]
YieldReaction ConditionsOperation in experiment
70% With N-ethyl-N,N-diisopropylamine In tetrahydrofuran; chloroform at 20℃; 70 Example 70; 3-f8-(2,6-difluorophenylV2-(4-methyl-1.4'-bipiperidin-r-ylV7-oxo-5,6J,8- tetrahvdropyrimido[4,5-
70% With N-ethyl-N,N-diisopropylamine In tetrahydrofuran; chloroform at 20℃; 70 To a solution of compound 3-[8-(2,6-difluorophenyl)-2-(methylsulfnyl)-7-oxo- 5,6,7,8-tetrahydropyrimido[4,5-3 (2mL) were added 4-methyl-l,4'-bipiperidine (40 mg, 0.22 mmol) and JV,jV-diisopropylethylamine (0.1 mL, 0.5 mmol). The resultant solution was stirred at room temperature over night. The result mixture was concentrated. CombiFlash chromatography (mobile phase DCM/DCM[90]+MeOH[7]+NH4OH[3]) provided the title compound as a white solid (31 mg, 70%). LC-MS m/z 618 (M + H)+; 1H- NMR (MeOD) δ 1.00 (d, 3 H), 1.22 (m, 2 H), 1.27 (d, 6 H), 1.38 (m, 3 H), 1.68 (d, 2H), 1.81 (d, 2 H), 2.19 (t, 2 H), 2.30 (s, 3 H), 2.50 (t, 1 H), 2.71 (t, 2H), 2.93 (d, 2 H), 4.11 (s, 2 H), 4.23 (m, 1 H), 4.45 (m, 2 H), 7.16 (t, 2 H), 7.46 (d, 1 H), 7.50 (m, 1 H), 7.68 (s, 1 H), 7.85 (d, I H).
Reference： [1]Current Patent Assignee: GLAXOSMITHKLINE PLC - WO2006/104889, 2006, A2 Location in patent: Page/Page column 177-178
[2]Current Patent Assignee: GLAXOSMITHKLINE PLC - WO2007/147109, 2007, A2 Location in patent: Page/Page column 159-160
  • 7
  • [ 116797-02-5 ]
  • [ 1223482-15-2 ]
  • [ 1201592-64-4 ]
YieldReaction ConditionsOperation in experiment
With tris-(dibenzylideneacetone)dipalladium(0); potassium <i>tert</i>-butylate; 2,2'-bis-(diphenylphosphino)-1,1'-binaphthyl In toluene at 100℃;
Reference： [1]Location in patent: scheme or table Wu, Tao; Nagle, Advait; Sakata, Tomoyo; Henson, Kerstin; Borboa, Rachel; Chen, Zhong; Kuhen, Kelli; Plouffe, David; Winzeler, Elizabeth; Adrian, Francisco; Tuntland, Tove; Chang, Jonathan; Simerson, Susan; Howard, Steven; Ek, Jared; Isbell, John; Deng, Xianming; Gray, Nathanael S.; Tully, David C.; Chatterjee, Arnab K. [Bioorganic and Medicinal Chemistry Letters, 2009, vol. 19, # 24, p. 6970 - 6974]
  • 8
  • [ 116797-02-5 ]
  • 3-azido-4-(prop-2-yn-1-yloxy)benzaldehyde [ No CAS ]
  • 1′-(3-azido-4-(prop-2-yn-1-yloxy)benzyl)-4-methyl-1,4′-bipiperidine [ No CAS ]
YieldReaction ConditionsOperation in experiment
0.0378 g With sodium tris(acetoxy)borohydride; acetic acid In dichloromethane at 20℃; for 28h; 1.X Synthesis of 1′-(3-azido-4-(prop-2-yn-1-yloxy)benzyl)-4-methyl-1,4′-bipiperidine A mixture of 3-methyl-1,4′-bipiperidine (0.0865 g, 0.048 mmol), the 3-azido-4-(prop-2-yn-1-yloxy)benzaldehyde (above), CH2Cl2 (2 mL), AcOH (0.027 mL, 0.47 mmol) and NaBH(OAc)3 (0.1425 g, 0.67 mmol) was stirred at room temperature for 28 h. The reaction was then quenched by saturated NaHCO3 solution (20 ml) at 0° C. and the generated bi-phase solution was extracted with CH2Cl2 (4×15 mL). The combined organic layers were dried over Na2SO4, filtered and concentrated under reduced pressure. The flash chromatography on silica gel (1:9 Methanol:CH2Cl2) provided the desired product as a yellow gel (0.0378 g, 22% over three steps). 1H NMR (400 MHz, CDCl3) δ 7.10-6.87 (m, 3H), 4.72 (d, J=2.4 Hz, 2H), 3.38 (s, 2H), 3.03-2.85 (m, 4H), 2.51 (t, J=2.4 Hz, 1H), 2.41 (s, 1H), 2.24 (d, J=11.8 Hz, 2H), 1.93 (td, J=11.9, 2.2 Hz, 2H), 1.84 (d, J=9.9 Hz, 2H), 1.61 (m, 5H), 1.37 (s, 2H), 0.91 (d, J=5.4 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 148.5, 133.0, 128.9, 125.9, 120.9, 114.1, 78.0, 76.1, 62.7, 61.9, 56.9, 53.1, 49.4, 33.8, 30.8, 27.5, 21.7; MS (ESI) m/z 368.2 (100%, [M+H]+).
Reference： [1]Current Patent Assignee: THE UNIVERSITY OF TEXAS SYSTEM - US2015/232444, 2015, A1 Location in patent: Paragraph 0394; 0397
  • 9
  • [ 116797-02-5 ]
  • benzyl (3-(chlorosulfonyl)-4-methoxyphenyl)carbamate [ No CAS ]
  • Benzyl (4-methoxy-3-((4-methyl-[1,4'-bipiperidin]-1'-yl)sulfonyl)phenyl)carbamate [ No CAS ]
YieldReaction ConditionsOperation in experiment
2.3318 g With N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃; for 21h; 1.XI A mixture of 4-methyl-1,4'-bipiperidine (1.2090 g, 6.64 mmol), benzyl (3-(chlorosulfonyl)-4-methoxyphenyl)carbamate (above), N, N-diisopropyl ethylamine (3 mL, 18.19 mmol), and CH2Cl2 (15 mL) were stirred at room temperature for 21 h. The solution was then diluted with CH2Cl2 (20 mL) and washed by saturated NaHCO3 solution (35 mL) and brine (35 mL) The organic layer was dried over Na2SO4, filtered and concentrated under reduced pressure. The residue was purified by flash chromatography on silica gel (1:19 Methanol:CH2Cl2) to afford the desired product as a white solid (2.3318 g, 77% three steps). mp 124-127° C.; 1H NMR (400 MHz, CDCl3) δ 7.80 (s, br, 1H), 7.67 (d, J=2.8 Hz, 1H), 7.43-7.30 (m, 4H), 6.95 (d, J=9.0 Hz, 1H), 6.89 (s, 1H), 5.18 (s, 2H), 3.89 (s, J=3.4 Hz, 1H), 3.87 (s, 3H), 2.79 (d, J=11.5 Hz, 2H), 2.66-2.53 (m, 2H), 2.29 (tt, J=11.6, 3.5 Hz, 1H), 2.19-2.06 (m, 2H), 1.96-1.72 (m, 3H), 1.68-1.48 (m, 4H), 1.31 (ddt, J=14.5, 6.7, 3.7 Hz, 1H), 1.25-1.10 (m, 2H), 0.89 (d, J=6.3 Hz, 3H); 13C NMR (100 MHz, CDCl3) 153.6, 153.0, 135.9, 130.8, 128.6, 128.4, 128.3, 126.9, 125.1, 122.2, 113.2, 67.2, 61.8, 56.4, 49.5, 45.9, 34.6, 31.1, 27.9, 21.9; MS (ESI) m/z 502.2 (100%, [M+H]+). 4-methoxy-3-((4-methyl-[1,4'-bipiperidin]-1'-yl)sulfonyl)aniline:
2.3318 g With N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃; for 21h;
Reference： [1]Current Patent Assignee: THE UNIVERSITY OF TEXAS SYSTEM - US2015/232444, 2015, A1 Location in patent: Paragraph 0398; 0401
[2]Budhipramono, Albert; De Brabander, Jef K.; Madhusudhan, Nikhil; McDonald, Jeffrey G.; Mitsche, Matthew A.; Nijhawan, Deepak; Theodoropoulos, Panayotis C.; Thompson, Bonne M.; Wang, Wentian [Journal of the American Chemical Society, 2020, vol. 142, # 13, p. 6128 - 6138]
  • 10
  • [ 116797-02-5 ]
  • [ 19551-16-7 ]
  • 2,7-bis((4-methyl-[1,4'-bipiperidin]-1'-yl)sulfonyl)naphthalene [ No CAS ]
YieldReaction ConditionsOperation in experiment
92% With N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃; 1.II 2,7-bis((4-methyl-[1,4′-bipiperidin]-1′-yl)sulfonyl)naphthalene: A mixture of amine (1.0 mmol), sulfonyl chloride (1.1 mmol), N,N-diisopropyl ethylamine (1.5 mmol), and CH2Cl2 (5 mL) was stirred at room temperature overnight. The reaction solution was then poured into saturated NaHCO3 solution (20 ml) and extracted by CH2Cl2 (3*20 mL). The combined organic layers were dried over Na2SO4, filtered and concentrated under reduced pressure. The residue was purified either through flash chromatography on silica gel with a MeOH:CH2Cl2 (or MeOH:EtOAc) mixture as eluent or by recrystallization from a mixture of CH2Cl2 and hexane to provide the sulfonamides.This compound was obtained as a white solid (92%) through flash chromatography (1:19 MeOH:CH2Cl2) after the reaction of 4-methyl-1,4′-bipiperidine (0.39 mmol) with naphthalene-2,7-disulfonyl dichloride (0.15 mmol) in CH2C12 (2.5 mL) in the presence of N, N-diisopropyl ethylamine (0.52 mmol). mp 265-268° C.; NMR (400 MHz, CDCl3) δ 8.42 (s, 2H), 8.04 (d, J=8.7 Hz, 2H), 7.89 (dd, J=8.6, 1.7 Hz, 2H), 3.92 (d, J=12.3 Hz, 4H), 2.75 (d, J=11.7 Hz, 4H), 2.32 (td, J=12.1, 2.4 Hz, 4H), 2.25-1.99 (m, 6H), 1.84 (d, J=11.5 Hz, 4H), 1.72-1.51 (m, 8H), 1.37-1.21 (m, 2H), 1.21-1.07 (m, 4H), 0.86 (d, J=6.3 Hz, 6H); 13C NMR (100 MHz, CDCl3) δ 136.0, 135.5, 131.3, 129.7, 129.2, 125.8, 61.4, 49.5, 46.2, 34.5, 31.0, 27.4, 21.8; MS (ESI) m/z 617.3 (100%, [M+H]+)
Reference： [1]Current Patent Assignee: THE UNIVERSITY OF TEXAS SYSTEM - US2015/232444, 2015, A1 Location in patent: Paragraph 0304; 0342
  • 11
  • [ 116797-02-5 ]
  • [ 98-09-9 ]
  • 4-methyl-1'-(phenylsulfonyl)-1,4'-bipiperidine [ No CAS ]
YieldReaction ConditionsOperation in experiment
92% With N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃; 1.II General Procedure for the Preparation of Sulfonamides from Sulfonyl Chlorides and Amines General procedure: A mixture of amine (1.0 mmol), sulfonyl chloride (1.1 mmol), N,N-diisopropyl ethylamine (1.5 mmol), and CH2Cl2 (5 mL) was stirred at room temperature overnight. The reaction solution was then poured into saturated NaHCO3 solution (20 ml) and extracted by CH2Cl2 (3*20 mL). The combined organic layers were dried over Na2SO4, filtered and concentrated under reduced pressure. The residue was purified either through flash chromatography on silica gel with a MeOH:CH2Cl2 (or MeOH:EtOAc) mixture as eluent or by recrystallization from a mixture of CH2Cl2 and hexane to provide the sulfonamides. 4-methyl-1'-(phenylsulfonyl)-1,4'-bipiperidine: This compound was obtained as a pale yellow solid (92%) through flash chromatography (1:9 MeOH:EtOAc) after the reaction between 4-methyl-1,4'-bipiperidine and benzenesulfonyl chloride. mp 154-156° C.; 1H NMR (500 MHz, CDCl3) δ 7.77 (dd, J=8.3, 1.4 Hz, 2H), 7.65-7.58 (m, 1H), 7.54 (dd, J=8.4, 7.0 Hz, 2H), 3.87 (d, J=11.9 Hz, 2H), 2.80 (d, J=11.8 Hz, 2H), 2.26 (m, 3H), 2.14 (t, J=11.4 Hz, 2H), 1.86 (d, J=11.7 Hz, 2H), 1.72-1.59 (m, 4H), 1.40-1.28 (m, 1H), 1.23 (m, 2H), 0.91 (d, J=6.4 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 136.0, 132.7, 129.0, 127.6, 61.3, 49.1, 46.1, 33.9, 30.8, 26.9, 21.7; MS (ESI) m/z 323.2 (100%, [M+H]+).
92% With N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃;
Reference： [1]Current Patent Assignee: THE UNIVERSITY OF TEXAS SYSTEM - US2015/232444, 2015, A1 Location in patent: Paragraph 0304; 0305
[2]Wang, Wentian; Zhang, Lu; Morlock, Lorraine; Williams, Noelle S.; Shay, Jerry W.; De Brabander, Jef K. [Journal of Medicinal Chemistry, 2019, vol. 62, # 10, p. 5217 - 5241]
  • 12
  • [ 116797-02-5 ]
  • [ 1679-64-7 ]
  • methyl 4-[(3-methyl-1,4'-bipiperidin-1'-yl)carbonyl]benzoate [ No CAS ]
YieldReaction ConditionsOperation in experiment
32% Stage #1: Monomethyl terephthalate With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 20℃; for 1h; Stage #2: 4-(4-methylpiperidin-1-yl)piperidine In N,N-dimethyl-formamide at 20℃; 22 Methyl 4-[(3-methyl-1,4'-bipiperidin-1'-yl)carbonyl]benzoate Example 22 Methyl 4-[(3-methyl-1,4'-bipiperidin-1'-yl)carbonyl]benzoate 2.7 g (15 mmol) of 4-(methoxycarbonyl)benzoic acid, 2.75 g (17.95 mmol) of HOBT, 3.44 g (17.95 mmol) of EDC and 7.82 ml (25 mmol) of N,N-diisopropylethylamine were dissolved in 60 ml of DMF, and the mixture was stirred at RT for 1 h. 3.0 g (16.45 mmol) of 4-(4-methylpiperidin-1-yl)piperidine were then added, and the mixture was stirred at RT overnight. The reaction mixture was allowed to stand at RT for 2 days. The mixture was poured into water and extracted with ethyl acetate. The organic phase was separated off, dried over magnesium sulphate and filtered, and the filtrate was concentrated. The residue was purified by preparative HPLC [Reprosil C18, 10 μm, 250 mm*40 mm (15% methanol/85% water (isocratic to 15 min) then gradient to 100% methanol) over a run time of 35 min]. After HPLC control, the product-containing fractions were combined and concentrated. The residue was dried under HV. This gave 1.7 g (32% of theory) of an oil. LC-MS [Method 1]: Rt=0.59 min; MS (ESIpos): m/z=345 (M+H)+ 1H-NMR (400 MHz, DMSO-d6): δ [ppm]=0.82 (d, 3H), 0.71-0.94 (m, 1H), 1.28-1.86 (m, 10H), 1.98-2.14 (m, 1H), 2.65-2.84 (m, 4H), 2.93-3.06 (m, 1H), 3.42-3.55 (m, 1H), 3.87 (s, 3H), 4.43-4.97 (m, 1H), 7.46-7.58 (m, 2H), 7.96-8.06 (m, 2H).
Reference： [1]Current Patent Assignee: BAYER AG - US2016/318866, 2016, A1 Location in patent: Paragraph 0931; 0932; 0933; 0934
  • 13
  • [ 116797-02-5 ]
  • [ 388118-89-6 ]
  • 7,8-dihydroxy-3-(4-methyl-[1,4-bipiperidinyl]-1'-carbonyl)-6-nitro-2H-chromen-2-one [ No CAS ]
YieldReaction ConditionsOperation in experiment
0.26g With potassium carbonate; N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate In N,N-dimethyl-formamide at 40℃; for 8h; 6 Example 6,Preparation of Compound 9 (7,8-dihydroxy-3-(4-methyl-[1,4-bipiperidinyl]-1'-carbonyl)-6-nitro-2H-chromen-2-one Preparation of In 50ml single neck flask was added 0.53g hydroxy substrate,Then 0.51 g of piperidine fragment 2 was added,Then add 20ml DMF,After stirring for 10 minutes,Add 1g of anhydrous potassium carbonate,After stirring for 10 minutes,Add 1.14g HATU,Warming to 40°C,Insulation reaction 8h.Cool to room temperaturefilter,The cake was washed first with 5ml DMF.Then wash with 5ml 1:1 hydrochloric acid.Finally washed with 5 ml of purified water,The resulting filter cake was air dried at 100°C for 1 hour.0.26 g of a pale yellow solid was obtained.
Reference： [1]Current Patent Assignee: SHANDONG UNIVERSITY - CN107935976, 2018, A Location in patent: Paragraph 0056; 0078-0079
  • 14
  • [ 116797-02-5 ]
  • 7-hydroxy-8-methyl-6-nitro-2-oxo-2H-benzopyran-3-carboxylic acid [ No CAS ]
  • 7-hydroxy-8-methyl-3-(4-methyl-[1,4-bipiperidinyl]-1'-carbonyl)-6-nitrate-2H-benzopyran-2-one [ No CAS ]
YieldReaction ConditionsOperation in experiment
0.30g With potassium carbonate; N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate In N,N-dimethyl-formamide at 40℃; for 8h; 5 Example 5 preparation of Compound 8 (7-Hydroxy-8-methyl-3-(4-methyl-[1,4-bipiperidinyl]-1'-carbonyl)-6-nitro-2H-benzopyran-2 -ketone In 50ml single neck flask was added 0.53g Methyl substrate,Then 0.51 g of piperidine fragment 2 was added,Then add 20ml DMF,After stirring for 10 minutes,Add 1g of anhydrous potassium carbonate,After stirring for 10 minutes,Add 1.14g HATU,Warming to 40°C,Insulation reaction 8h.Cool to room temperaturefilter,The cake was washed first with 5ml DMF.Then wash with 5ml 1:1 hydrochloric acid.Finally washed with 5 ml of purified water,The resulting filter cake was air dried at 100°C for 1 hour.0.30 g of a pale yellow solid is obtained.
Reference： [1]Current Patent Assignee: SHANDONG UNIVERSITY - CN107935976, 2018, A Location in patent: Paragraph 0056; 0075-0076
  • 15
  • [ 116797-02-5 ]
  • [ 98-58-8 ]
  • 1'-((4-bromophenyl)sulfonyl)-4-methyl-1,4'-bipiperidine [ No CAS ]
YieldReaction ConditionsOperation in experiment
83% With N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃;
Reference： [1]Wang, Wentian; Zhang, Lu; Morlock, Lorraine; Williams, Noelle S.; Shay, Jerry W.; De Brabander, Jef K. [Journal of Medicinal Chemistry, 2019, vol. 62, # 10, p. 5217 - 5241]
  • 16
  • [ 116797-02-5 ]
  • [ 773-64-8 ]
  • 1'-(mesitylsulfonyl)-4-methyl-1,4'-bipiperidine [ No CAS ]
YieldReaction ConditionsOperation in experiment
95% With N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃;
Reference： [1]Wang, Wentian; Zhang, Lu; Morlock, Lorraine; Williams, Noelle S.; Shay, Jerry W.; De Brabander, Jef K. [Journal of Medicinal Chemistry, 2019, vol. 62, # 10, p. 5217 - 5241]
  • 17
  • [ 116797-02-5 ]
  • [ 98-68-0 ]
  • 1'-((4-methoxyphenyl)sulfonyl)-4-methyl-1,4'-bipiperidine [ No CAS ]
YieldReaction ConditionsOperation in experiment
94% With N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃;
Reference： [1]Wang, Wentian; Zhang, Lu; Morlock, Lorraine; Williams, Noelle S.; Shay, Jerry W.; De Brabander, Jef K. [Journal of Medicinal Chemistry, 2019, vol. 62, # 10, p. 5217 - 5241]
  • 18
  • [ 116797-02-5 ]
  • [ 98-74-8 ]
  • 4-methyl-1'-((4-nitrophenyl)sulfonyl)-1,4'-bipiperidine [ No CAS ]
YieldReaction ConditionsOperation in experiment
76% With N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃;
Reference： [1]Wang, Wentian; Zhang, Lu; Morlock, Lorraine; Williams, Noelle S.; Shay, Jerry W.; De Brabander, Jef K. [Journal of Medicinal Chemistry, 2019, vol. 62, # 10, p. 5217 - 5241]
  • 19
  • [ 116797-02-5 ]
  • [ 69812-51-7 ]
  • methyl 4-((4-methyl-[1,4'-bipiperidin]-1'-yl)sulfonyl)-benzoate [ No CAS ]
YieldReaction ConditionsOperation in experiment
54% With N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃;
Reference： [1]Wang, Wentian; Zhang, Lu; Morlock, Lorraine; Williams, Noelle S.; Shay, Jerry W.; De Brabander, Jef K. [Journal of Medicinal Chemistry, 2019, vol. 62, # 10, p. 5217 - 5241]
  • 20
  • [ 116797-02-5 ]
  • [ 49584-26-1 ]
  • 4-((4-methyl-[1,4'-bipiperidin]-1'-yl)sulfonyl)benzonitrile [ No CAS ]
YieldReaction ConditionsOperation in experiment
92% With N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃;
Reference： [1]Wang, Wentian; Zhang, Lu; Morlock, Lorraine; Williams, Noelle S.; Shay, Jerry W.; De Brabander, Jef K. [Journal of Medicinal Chemistry, 2019, vol. 62, # 10, p. 5217 - 5241]
  • 21
  • [ 116797-02-5 ]
  • [ 98-59-9 ]
  • 4-methyl-1‘-tosyl-1,4’-bipiperidine [ No CAS ]
YieldReaction ConditionsOperation in experiment
67% With N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃;
Reference： [1]Wang, Wentian; Zhang, Lu; Morlock, Lorraine; Williams, Noelle S.; Shay, Jerry W.; De Brabander, Jef K. [Journal of Medicinal Chemistry, 2019, vol. 62, # 10, p. 5217 - 5241]
  • 22
  • [ 116797-02-5 ]
  • [ 16712-69-9 ]
  • 1'-((4-ethylphenyl)sulfonyl)-4-methyl-1,4'-bipiperidine [ No CAS ]
YieldReaction ConditionsOperation in experiment
95% With N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃;
Reference： [1]Wang, Wentian; Zhang, Lu; Morlock, Lorraine; Williams, Noelle S.; Shay, Jerry W.; De Brabander, Jef K. [Journal of Medicinal Chemistry, 2019, vol. 62, # 10, p. 5217 - 5241]
  • 23
  • [ 116797-02-5 ]
  • [ 54997-90-9 ]
  • 1'-((4-isopropylphenyl)sulfonyl)-4-methyl-1,4'-bipiperidine [ No CAS ]
YieldReaction ConditionsOperation in experiment
79% With N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃;
Reference： [1]Wang, Wentian; Zhang, Lu; Morlock, Lorraine; Williams, Noelle S.; Shay, Jerry W.; De Brabander, Jef K. [Journal of Medicinal Chemistry, 2019, vol. 62, # 10, p. 5217 - 5241]
  • 24
  • [ 116797-02-5 ]
  • [ 15084-51-2 ]
  • 1'-((4-(tert-butyl)phenyl)sulfonyl)-4-methyl-1,4'-bipiperidine [ No CAS ]
YieldReaction ConditionsOperation in experiment
85% With N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃;
Reference： [1]Wang, Wentian; Zhang, Lu; Morlock, Lorraine; Williams, Noelle S.; Shay, Jerry W.; De Brabander, Jef K. [Journal of Medicinal Chemistry, 2019, vol. 62, # 10, p. 5217 - 5241]
  • 25
  • [ 116797-02-5 ]
  • [ 2991-42-6 ]
  • 4-methyl-1'-((4-(trifluoromethyl)phenyl)sulfonyl)-1,4'-bipiperidine [ No CAS ]
YieldReaction ConditionsOperation in experiment
87% With N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃;
Reference： [1]Wang, Wentian; Zhang, Lu; Morlock, Lorraine; Williams, Noelle S.; Shay, Jerry W.; De Brabander, Jef K. [Journal of Medicinal Chemistry, 2019, vol. 62, # 10, p. 5217 - 5241]
  • 26
  • [ 116797-02-5 ]
  • [ 98-60-2 ]
  • 1'-((4-chlorophenyl)sulfonyl)-4-methyl-1,4'-bipiperidine [ No CAS ]
YieldReaction ConditionsOperation in experiment
67% With N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃;
Reference： [1]Wang, Wentian; Zhang, Lu; Morlock, Lorraine; Williams, Noelle S.; Shay, Jerry W.; De Brabander, Jef K. [Journal of Medicinal Chemistry, 2019, vol. 62, # 10, p. 5217 - 5241]
  • 27
  • [ 116797-02-5 ]
  • [ 58076-32-7 ]
  • 4-methyl-1'-((4-propoxyphenyl)sulfonyl)-1,4'-bipiperidine [ No CAS ]
YieldReaction ConditionsOperation in experiment
95% With N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃;
Reference： [1]Wang, Wentian; Zhang, Lu; Morlock, Lorraine; Williams, Noelle S.; Shay, Jerry W.; De Brabander, Jef K. [Journal of Medicinal Chemistry, 2019, vol. 62, # 10, p. 5217 - 5241]
  • 28
  • [ 116797-02-5 ]
  • [ 1138-56-3 ]
  • 1'-((4-butoxyphenyl)sulfonyl)-4-methyl-1,4'-bipiperidine [ No CAS ]
YieldReaction ConditionsOperation in experiment
82% With N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃;
Reference： [1]Wang, Wentian; Zhang, Lu; Morlock, Lorraine; Williams, Noelle S.; Shay, Jerry W.; De Brabander, Jef K. [Journal of Medicinal Chemistry, 2019, vol. 62, # 10, p. 5217 - 5241]
  • 29
  • [ 116797-02-5 ]
  • [ 87001-32-9 ]
  • 1'-((4-(benzyloxy)phenyl)sulfonyl)-4-methyl-1,4'-bipiperidine [ No CAS ]
Reference： [1]Journal of Medicinal Chemistry,2019,vol. 62,p. 5217 - 5241
  • 30
  • [ 116797-02-5 ]
  • [ 94108-56-2 ]
  • 4-methyl-1'-((4-(trifluoromethoxy)phenyl)sulfonyl)-1,4'-bipiperidine [ No CAS ]
YieldReaction ConditionsOperation in experiment
95% With N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃;
Reference： [1]Wang, Wentian; Zhang, Lu; Morlock, Lorraine; Williams, Noelle S.; Shay, Jerry W.; De Brabander, Jef K. [Journal of Medicinal Chemistry, 2019, vol. 62, # 10, p. 5217 - 5241]
  • 31
  • [ 116797-02-5 ]
  • 4-[(difluoromethyl)oxy]benzenesulfonyl chloride [ No CAS ]
  • 1'-((4-(difluoromethoxy)phenyl)sulfonyl)-4-methyl-1,4'-bipiperidine [ No CAS ]
YieldReaction ConditionsOperation in experiment
69% With N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃;
Reference： [1]Wang, Wentian; Zhang, Lu; Morlock, Lorraine; Williams, Noelle S.; Shay, Jerry W.; De Brabander, Jef K. [Journal of Medicinal Chemistry, 2019, vol. 62, # 10, p. 5217 - 5241]
  • 32
  • [ 116797-02-5 ]
  • [ 10130-74-2 ]
  • 1'-((3-methoxyphenyl)sulfonyl)-4-methyl-1,4'-bipiperidine [ No CAS ]
YieldReaction ConditionsOperation in experiment
85% With N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃;
Reference： [1]Wang, Wentian; Zhang, Lu; Morlock, Lorraine; Williams, Noelle S.; Shay, Jerry W.; De Brabander, Jef K. [Journal of Medicinal Chemistry, 2019, vol. 62, # 10, p. 5217 - 5241]
  • 33
  • [ 116797-02-5 ]
  • [ 121-51-7 ]
  • 4-methyl-1'-((3-nitrophenyl)sulfonyl)-1,4'-bipiperidine [ No CAS ]
YieldReaction ConditionsOperation in experiment
77% With N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃;
Reference： [1]Wang, Wentian; Zhang, Lu; Morlock, Lorraine; Williams, Noelle S.; Shay, Jerry W.; De Brabander, Jef K. [Journal of Medicinal Chemistry, 2019, vol. 62, # 10, p. 5217 - 5241]
  • 34
  • [ 116797-02-5 ]
  • [ 1899-93-0 ]
  • 4-methyl-1'-(m-tolylsulfonyl)-1,4'-bipiperidine [ No CAS ]
YieldReaction ConditionsOperation in experiment
86% With N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃;
Reference： [1]Wang, Wentian; Zhang, Lu; Morlock, Lorraine; Williams, Noelle S.; Shay, Jerry W.; De Brabander, Jef K. [Journal of Medicinal Chemistry, 2019, vol. 62, # 10, p. 5217 - 5241]
  • 35
  • [ 116797-02-5 ]
  • [ 777-44-6 ]
  • 4-methyl-1'-((3-(trifluoromethyl)phenyl)sulfonyl)-1,4'-bipiperidine [ No CAS ]
YieldReaction ConditionsOperation in experiment
90% With N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃;
Reference： [1]Wang, Wentian; Zhang, Lu; Morlock, Lorraine; Williams, Noelle S.; Shay, Jerry W.; De Brabander, Jef K. [Journal of Medicinal Chemistry, 2019, vol. 62, # 10, p. 5217 - 5241]
  • 36
  • [ 116797-02-5 ]
  • [ 2888-06-4 ]
  • 1'-((3-chlorophenyl)sulfonyl)-4-methyl-1,4'-bipiperidine [ No CAS ]
YieldReaction ConditionsOperation in experiment
74% With N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃;
Reference： [1]Wang, Wentian; Zhang, Lu; Morlock, Lorraine; Williams, Noelle S.; Shay, Jerry W.; De Brabander, Jef K. [Journal of Medicinal Chemistry, 2019, vol. 62, # 10, p. 5217 - 5241]
  • 37
  • [ 116797-02-5 ]
  • [ 2905-24-0 ]
  • 1'-((3-bromophenyl)sulfonyl)-4-methyl-1,4'-bipiperidine [ No CAS ]
YieldReaction ConditionsOperation in experiment
65% With N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃;
Reference： [1]Wang, Wentian; Zhang, Lu; Morlock, Lorraine; Williams, Noelle S.; Shay, Jerry W.; De Brabander, Jef K. [Journal of Medicinal Chemistry, 2019, vol. 62, # 10, p. 5217 - 5241]
  • 38
  • [ 116797-02-5 ]
  • [ 2905-25-1 ]
  • 1'-((2-bromophenyl)sulfonyl)-4-methyl-1,4'-bipiperidine [ No CAS ]
YieldReaction ConditionsOperation in experiment
95% With N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃;
Reference： [1]Wang, Wentian; Zhang, Lu; Morlock, Lorraine; Williams, Noelle S.; Shay, Jerry W.; De Brabander, Jef K. [Journal of Medicinal Chemistry, 2019, vol. 62, # 10, p. 5217 - 5241]
  • 39
  • [ 116797-02-5 ]
  • [ 23095-31-0 ]
  • 1'-((3,4-dimethoxyphenyl)sulfonyl)-4-methyl-1,4'-bipiperidine [ No CAS ]
YieldReaction ConditionsOperation in experiment
78% With N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃;
Reference： [1]Wang, Wentian; Zhang, Lu; Morlock, Lorraine; Williams, Noelle S.; Shay, Jerry W.; De Brabander, Jef K. [Journal of Medicinal Chemistry, 2019, vol. 62, # 10, p. 5217 - 5241]
  • 40
  • [ 116797-02-5 ]
  • [ 1483-28-9 ]
  • 1'-((2,5-dimethoxyphenyl)sulfonyl)-4-methyl-1,4'-bipiperidine [ No CAS ]
YieldReaction ConditionsOperation in experiment
95% With N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃;
Reference： [1]Wang, Wentian; Zhang, Lu; Morlock, Lorraine; Williams, Noelle S.; Shay, Jerry W.; De Brabander, Jef K. [Journal of Medicinal Chemistry, 2019, vol. 62, # 10, p. 5217 - 5241]
  • 41
  • [ 116797-02-5 ]
  • [ 23095-05-8 ]
  • 1'-((5-bromo-2-methoxyphenyl)sulfonyl)-4-methyl-1,4'-bipiperidine [ No CAS ]
YieldReaction ConditionsOperation in experiment
92% With N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃;
Reference： [1]Wang, Wentian; Zhang, Lu; Morlock, Lorraine; Williams, Noelle S.; Shay, Jerry W.; De Brabander, Jef K. [Journal of Medicinal Chemistry, 2019, vol. 62, # 10, p. 5217 - 5241]
  • 42
  • [ 116797-02-5 ]
  • [ 216394-11-5 ]
  • 1‘-((2-methoxy-4-methylphenyl)sulfonyl)-4-methyl-1,4’-bipiperidine [ No CAS ]
YieldReaction ConditionsOperation in experiment
88% With N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃;
Reference： [1]Wang, Wentian; Zhang, Lu; Morlock, Lorraine; Williams, Noelle S.; Shay, Jerry W.; De Brabander, Jef K. [Journal of Medicinal Chemistry, 2019, vol. 62, # 10, p. 5217 - 5241]
  • 43
  • [ 116797-02-5 ]
  • [ 39234-83-8 ]
  • 4-methyl-1'-((4-nitro-3-(trifluoromethyl)phenyl)sulfonyl)-1,4'- bipiperidine [ No CAS ]
YieldReaction ConditionsOperation in experiment
86% With N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃;
Reference： [1]Wang, Wentian; Zhang, Lu; Morlock, Lorraine; Williams, Noelle S.; Shay, Jerry W.; De Brabander, Jef K. [Journal of Medicinal Chemistry, 2019, vol. 62, # 10, p. 5217 - 5241]
  • 44
  • [ 116797-02-5 ]
  • [ 197960-31-9 ]
  • 4-methyl-2-((4-methyl-[1,4'-bipiperidin]-1'-yl)sulfonyl)benzonitrile [ No CAS ]
YieldReaction ConditionsOperation in experiment
94% With N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃;
Reference： [1]Wang, Wentian; Zhang, Lu; Morlock, Lorraine; Williams, Noelle S.; Shay, Jerry W.; De Brabander, Jef K. [Journal of Medicinal Chemistry, 2019, vol. 62, # 10, p. 5217 - 5241]
  • 45
  • [ 116797-02-5 ]
  • [ 2905-30-8 ]
  • 1'-((3,4-dimethylphenyl)sulfonyl)-4-methyl-1,4'-bipiperidine [ No CAS ]
YieldReaction ConditionsOperation in experiment
89% With N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃;
Reference： [1]Wang, Wentian; Zhang, Lu; Morlock, Lorraine; Williams, Noelle S.; Shay, Jerry W.; De Brabander, Jef K. [Journal of Medicinal Chemistry, 2019, vol. 62, # 10, p. 5217 - 5241]
  • 46
  • [ 116797-02-5 ]
  • 4-bromo-2-ethylbenzene-1-sulfonyl chloride [ No CAS ]
  • 1'-((4-bromo-2-ethylphenyl)sulfonyl)-4-methyl-1,4'-bipiperidine [ No CAS ]
YieldReaction ConditionsOperation in experiment
92% With N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃;
Reference： [1]Wang, Wentian; Zhang, Lu; Morlock, Lorraine; Williams, Noelle S.; Shay, Jerry W.; De Brabander, Jef K. [Journal of Medicinal Chemistry, 2019, vol. 62, # 10, p. 5217 - 5241]
  • 47
  • [ 116797-02-5 ]
  • [ 32333-53-2 ]
  • 1'-((4-chloro-3-(trifluoromethyl)phenyl)sulfonyl)-4-methyl-1,4'-bipiperidine [ No CAS ]
YieldReaction ConditionsOperation in experiment
95% With N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃;
Reference： [1]Wang, Wentian; Zhang, Lu; Morlock, Lorraine; Williams, Noelle S.; Shay, Jerry W.; De Brabander, Jef K. [Journal of Medicinal Chemistry, 2019, vol. 62, # 10, p. 5217 - 5241]
  • 48
  • [ 116797-02-5 ]
  • [ 98-31-7 ]
  • 1'-((3,4-dichlorophenyl)sulfonyl)-4-methyl-1,4'-bipiperidine [ No CAS ]
YieldReaction ConditionsOperation in experiment
86% With N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃;
Reference： [1]Wang, Wentian; Zhang, Lu; Morlock, Lorraine; Williams, Noelle S.; Shay, Jerry W.; De Brabander, Jef K. [Journal of Medicinal Chemistry, 2019, vol. 62, # 10, p. 5217 - 5241]
  • 49
  • [ 116797-02-5 ]
  • [ 16271-33-3 ]
  • 1'-((2,4-dichlorophenyl)sulfonyl)-4-methyl-1,4'-bipiperidine [ No CAS ]
YieldReaction ConditionsOperation in experiment
88% With N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃;
Reference： [1]Wang, Wentian; Zhang, Lu; Morlock, Lorraine; Williams, Noelle S.; Shay, Jerry W.; De Brabander, Jef K. [Journal of Medicinal Chemistry, 2019, vol. 62, # 10, p. 5217 - 5241]
  • 50
  • [ 116797-02-5 ]
  • [ 705-21-5 ]
  • 1'-((3,5-dichlorophenyl)sulfonyl)-4-methyl-1,4'-bipiperidine [ No CAS ]
YieldReaction ConditionsOperation in experiment
92% With N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃;
Reference： [1]Wang, Wentian; Zhang, Lu; Morlock, Lorraine; Williams, Noelle S.; Shay, Jerry W.; De Brabander, Jef K. [Journal of Medicinal Chemistry, 2019, vol. 62, # 10, p. 5217 - 5241]
  • 51
  • [ 116797-02-5 ]
  • [ 874801-46-4 ]
  • 1'-((4-bromo-3-chlorophenyl)sulfonyl)-4-methyl-1,4'-bipiperidine [ No CAS ]
YieldReaction ConditionsOperation in experiment
95% With N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃;
Reference： [1]Wang, Wentian; Zhang, Lu; Morlock, Lorraine; Williams, Noelle S.; Shay, Jerry W.; De Brabander, Jef K. [Journal of Medicinal Chemistry, 2019, vol. 62, # 10, p. 5217 - 5241]
  • 52
  • [ 116797-02-5 ]
  • [ 13918-92-8 ]
  • 1'-((2,4-difluorophenyl)sulfonyl)-4-methyl-1,4'-bipiperidine [ No CAS ]
YieldReaction ConditionsOperation in experiment
88% With N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃;
Reference： [1]Wang, Wentian; Zhang, Lu; Morlock, Lorraine; Williams, Noelle S.; Shay, Jerry W.; De Brabander, Jef K. [Journal of Medicinal Chemistry, 2019, vol. 62, # 10, p. 5217 - 5241]
  • 53
  • 4-bromo-2-(trifluoromethoxy)benzene-1-sulfonyl chloride [ No CAS ]
  • [ 116797-02-5 ]
  • 1'-((4-bromo-2-(trifluoromethoxy)phenyl)sulfonyl)-4-methyl-1,4'-bipiperidine [ No CAS ]
YieldReaction ConditionsOperation in experiment
67% With N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃;
Reference： [1]Wang, Wentian; Zhang, Lu; Morlock, Lorraine; Williams, Noelle S.; Shay, Jerry W.; De Brabander, Jef K. [Journal of Medicinal Chemistry, 2019, vol. 62, # 10, p. 5217 - 5241]
  • 54
  • [ 116797-02-5 ]
  • 5-isopropyl-4-methoxy-2-methylbenzene-1-sulfonyl chloride [ No CAS ]
  • 1'-((5-isopropyl-4-methoxy-2-methylphenyl)sulfonyl)-4-methyl-1,4'-bipiperidine [ No CAS ]
YieldReaction ConditionsOperation in experiment
94% With N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃;
Reference： [1]Wang, Wentian; Zhang, Lu; Morlock, Lorraine; Williams, Noelle S.; Shay, Jerry W.; De Brabander, Jef K. [Journal of Medicinal Chemistry, 2019, vol. 62, # 10, p. 5217 - 5241]
  • 55
  • [ 116797-02-5 ]
  • [ 28286-86-4 ]
  • 1'-((2,4-dichloro-5-methylphenyl)sulfonyl)-4-methyl-1,4'-bipiperidine [ No CAS ]
YieldReaction ConditionsOperation in experiment
83% With N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃;
Reference： [1]Wang, Wentian; Zhang, Lu; Morlock, Lorraine; Williams, Noelle S.; Shay, Jerry W.; De Brabander, Jef K. [Journal of Medicinal Chemistry, 2019, vol. 62, # 10, p. 5217 - 5241]
  • 56
  • [ 116797-02-5 ]
  • 2,4-dichloro-6-methylbenzene-1-sulfonyl chloride [ No CAS ]
  • 1'-((2,4-dichloro-6-methylphenyl)sulfonyl)-4-methyl-1,4'-bipiperidine [ No CAS ]
YieldReaction ConditionsOperation in experiment
93% With N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃;
Reference： [1]Wang, Wentian; Zhang, Lu; Morlock, Lorraine; Williams, Noelle S.; Shay, Jerry W.; De Brabander, Jef K. [Journal of Medicinal Chemistry, 2019, vol. 62, # 10, p. 5217 - 5241]
  • 57
  • [ 116797-02-5 ]
  • 4-bromo-3,5-difluorobenzene-1-sulfonyl chloride [ No CAS ]
  • 1'-((4-bromo-3,5-difluorophenyl)sulfonyl)-4-methyl-1,4'-bipiperidine [ No CAS ]
YieldReaction ConditionsOperation in experiment
73% With N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃;
Reference： [1]Wang, Wentian; Zhang, Lu; Morlock, Lorraine; Williams, Noelle S.; Shay, Jerry W.; De Brabander, Jef K. [Journal of Medicinal Chemistry, 2019, vol. 62, # 10, p. 5217 - 5241]
  • 58
  • [ 116797-02-5 ]
  • [ 2688-90-6 ]
  • 1'-([1,1'-biphenyl]-2-ylsulfonyl)-4-methyl-1,4'-bipiperidine [ No CAS ]
YieldReaction ConditionsOperation in experiment
95% With N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃;
Reference： [1]Wang, Wentian; Zhang, Lu; Morlock, Lorraine; Williams, Noelle S.; Shay, Jerry W.; De Brabander, Jef K. [Journal of Medicinal Chemistry, 2019, vol. 62, # 10, p. 5217 - 5241]
  • 59
  • [ 116797-02-5 ]
  • [ 20443-74-7 ]
  • 1'-((4'-chloro-[1,1'-biphenyl]-4-yl)sulfonyl)-4-methyl-1,4'-bipiperidine [ No CAS ]
YieldReaction ConditionsOperation in experiment
87% With N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃;
Reference： [1]Wang, Wentian; Zhang, Lu; Morlock, Lorraine; Williams, Noelle S.; Shay, Jerry W.; De Brabander, Jef K. [Journal of Medicinal Chemistry, 2019, vol. 62, # 10, p. 5217 - 5241]
  • 60
  • [ 116797-02-5 ]
  • [ 202752-04-3 ]
  • 1'-((4'-methoxy-[1,1'-biphenyl]-4-yl)sulfonyl)-4-methyl-1,4'-bipiperidine [ No CAS ]
YieldReaction ConditionsOperation in experiment
92% With N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃;
Reference： [1]Wang, Wentian; Zhang, Lu; Morlock, Lorraine; Williams, Noelle S.; Shay, Jerry W.; De Brabander, Jef K. [Journal of Medicinal Chemistry, 2019, vol. 62, # 10, p. 5217 - 5241]
  • 61
  • [ 116797-02-5 ]
  • [ 186551-03-1 ]
  • 1'-((2'-methoxy-[1,1'-biphenyl]-4-yl)sulfonyl)-4-methyl-1,4'-bipiperidine [ No CAS ]
YieldReaction ConditionsOperation in experiment
88% With N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃;
Reference： [1]Wang, Wentian; Zhang, Lu; Morlock, Lorraine; Williams, Noelle S.; Shay, Jerry W.; De Brabander, Jef K. [Journal of Medicinal Chemistry, 2019, vol. 62, # 10, p. 5217 - 5241]
  • 62
  • [ 116797-02-5 ]
  • 2'-fluoro[1,1'-biphenyl]-4-sulfonyl chloride [ No CAS ]
  • 1'-((2'-fluoro-[1,1'-biphenyl]-4-yl)sulfonyl)-4-methyl-1,4'-bipiperidine [ No CAS ]
YieldReaction ConditionsOperation in experiment
73% With N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃;
Reference： [1]Wang, Wentian; Zhang, Lu; Morlock, Lorraine; Williams, Noelle S.; Shay, Jerry W.; De Brabander, Jef K. [Journal of Medicinal Chemistry, 2019, vol. 62, # 10, p. 5217 - 5241]
  • 63
  • [ 116797-02-5 ]
  • [ 16133-25-8 ]
  • 4-methyl-1'-(pyridin-3-ylsulfonyl)-1,4'-bipiperidine [ No CAS ]
YieldReaction ConditionsOperation in experiment
86% With N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃;
Reference： [1]Wang, Wentian; Zhang, Lu; Morlock, Lorraine; Williams, Noelle S.; Shay, Jerry W.; De Brabander, Jef K. [Journal of Medicinal Chemistry, 2019, vol. 62, # 10, p. 5217 - 5241]
  • 64
  • [ 116797-02-5 ]
  • [ 6684-06-6 ]
  • 1'-((2-chloropyridin-3-yl)sulfonyl)-4-methyl-1,4'-bipiperidine [ No CAS ]
YieldReaction ConditionsOperation in experiment
71% With N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃;
Reference： [1]Wang, Wentian; Zhang, Lu; Morlock, Lorraine; Williams, Noelle S.; Shay, Jerry W.; De Brabander, Jef K. [Journal of Medicinal Chemistry, 2019, vol. 62, # 10, p. 5217 - 5241]
  • 65
  • [ 116797-02-5 ]
  • [ 1089330-70-0 ]
  • 1'-((2-fluoropyridin-3-yl)sulfonyl)-4-methyl-1,4'-bipiperidine [ No CAS ]
YieldReaction ConditionsOperation in experiment
95% With N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃;
Reference： [1]Wang, Wentian; Zhang, Lu; Morlock, Lorraine; Williams, Noelle S.; Shay, Jerry W.; De Brabander, Jef K. [Journal of Medicinal Chemistry, 2019, vol. 62, # 10, p. 5217 - 5241]
  • 66
  • [ 116797-02-5 ]
  • [ 6684-39-5 ]
  • 1'-((6-chloropyridin-3-yl)sulfonyl)-4-methyl-1,4'-bipiperidine [ No CAS ]
YieldReaction ConditionsOperation in experiment
80% With N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃;
Reference： [1]Wang, Wentian; Zhang, Lu; Morlock, Lorraine; Williams, Noelle S.; Shay, Jerry W.; De Brabander, Jef K. [Journal of Medicinal Chemistry, 2019, vol. 62, # 10, p. 5217 - 5241]
  • 67
  • [ 116797-02-5 ]
  • [ 65001-21-0 ]
  • 1'-((5-bromopyridin-3-yl)sulfonyl)-4-methyl-1,4'-bipiperidine [ No CAS ]
Reference： [1]Journal of Medicinal Chemistry,2019,vol. 62,p. 5217 - 5241
  • 68
  • [ 116797-02-5 ]
  • [ 124788-36-9 ]
  • 1,3-dimethyl-5-((4-methyl-[1,4'-bipiperidin]-1'-yl)sulfonyl)pyrimidine-2,4(1H,3H)-dione [ No CAS ]
YieldReaction ConditionsOperation in experiment
78% With N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃;
Reference： [1]Wang, Wentian; Zhang, Lu; Morlock, Lorraine; Williams, Noelle S.; Shay, Jerry W.; De Brabander, Jef K. [Journal of Medicinal Chemistry, 2019, vol. 62, # 10, p. 5217 - 5241]

Tags: 116797-02-5 synthesis path| 116797-02-5 SDS| 116797-02-5 COA| 116797-02-5 purity| 116797-02-5 application| 116797-02-5 NMR| 116797-02-5 COA| 116797-02-5 structure

Same Skeleton Products
Related Products
Historical Records

Related Parent Nucleus of
[ 116797-02-5 ]

Piperidines

Chemical Structure| 883543-12-2

[ 883543-12-2 ]

4-Methyl-1-(2-(piperidin-2-yl)ethyl)piperidine

Similarity: 1.00

Chemical Structure| 1287033-73-1

[ 1287033-73-1 ]

4-Methyl-1,4'-bipiperidine hydrochloride

Similarity: 1.00

Chemical Structure| 883533-01-5

[ 883533-01-5 ]

(1'-Methyl-[1,4'-bipiperidin]-4-yl)methanamine

Similarity: 0.96

Chemical Structure| 1219980-69-4

[ 1219980-69-4 ]

4-Methyl-1-(2-(piperidin-2-yl)ethyl)piperidine dihydrochloride

Similarity: 0.96

Chemical Structure| 1089279-43-5

[ 1089279-43-5 ]

4-Methyl-1,4'-bipiperidine dihydrochloride

Similarity: 0.96